[HTML] mdpi.com

[HTML][HTML] γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy

SP Papadakos, K Arvanitakis, IE Stergiou… - International journal of …, 2024 - mdpi.com
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment
options and a poor prognosis for advanced-stage patients. Recent advancements in cancer …
被引用次数：2 相关文章

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy

S Papadakos, K Arvanitakis, I Stergiou… - … Journal of Molecular …, 2024 - europepmc.org
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment
options and a poor prognosis for advanced-stage patients. Recent advancements in cancer …

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy.

SP Papadakos, K Arvanitakis… - International …, 2024 - search.ebscohost.com
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment
options and a poor prognosis for advanced-stage patients. Recent advancements in cancer …

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy

SP Papadakos, K Arvanitakis… - International …, 2024 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment
options and a poor prognosis for advanced-stage patients. Recent advancements in cancer …
[HTML] nih.gov

[HTML][HTML] γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy

SP Papadakos, K Arvanitakis, IE Stergiou… - … Journal of Molecular …, 2024 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment
options and a poor prognosis for advanced-stage patients. Recent advancements in cancer …

γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy.

SP Papadakos, K Arvanitakis, IE Stergiou… - … Journal of Molecular …, 2024 - europepmc.org
Hepatocellular carcinoma (HCC) remains a global health challenge with limited treatment
options and a poor prognosis for advanced-stage patients. Recent advancements in cancer …